Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 372-376, June 2010

Is there a role for a specialized follow-up clinic for survivors of pediatric cancer?

  • Pinki K. Prasad

      Affiliations

    • Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, United States
    • Corresponding Author InformationCorresponding author.
  • ,
  • Travis Bowles

      Affiliations

    • Internal Medicine and Pediatrics, Adult Cancer Survivorship Program, Vanderbilt Ingram Cancer Center, Nashville, TN 37232, United States
  • ,
  • Debra L. Friedman

      Affiliations

    • Cancer Control and Prevention Program, Vanderbilt Ingram Cancer Center, Nashville, TN 37232, United States

published online 02 March 2010.

Abstract 

Due to advances in chemotherapy and supportive care, greater than 70% of patients with childhood cancer will survive 5years. However, there are long-term physiological and psychological sequelae of these treatments that may not manifest until pediatric survivors are into adulthood. Various studies done in the long-term pediatric survivors have noted that they are at increased risk for poor health and for chronic health problems. One complicating factor in treating these patients for their health problems is that many childhood cancer survivors are unaware of their past medical history and what their past cancer treatment entailed. There are also a number of barriers to medical care in survivors of childhood cancer which include inadequate insurance coverage for many and lack of knowledge of long-term effects physicians. As pediatric cancer survivors age they usually transition to community physicians. This paper proposes different models for follow-up clinics for survivors of pediatric cancers so childhood cancer survivors are not be subjected to cost ineffective or excessive evaluations but rather medical screening tests that are risk and guidelines that are set forth by experts.

Keywords: Childhood cancer, Survivors, Barriers, Healthcare

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(10)00034-4

doi:10.1016/j.ctrv.2010.02.014

Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 372-376, June 2010